MiNK Therapeutics enters $50M ATM equity offering agreement with B. Riley Securities

MiNK Therapeutics, Inc.

Maximum aggregate offering price of $50M in common stock to be sold at market prices.
Sales agent is B. Riley Securities, Inc.; shares issued via existing Form S-3 registration statement.
Agreement dated July 15, 2025; no minimum sales amount required.

item 1.01 item 9.01

MiNK Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-159017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.